Centene: Mixed Q1 Results As Wellcare Beds In – Still A Good Time To Buy
… short-to-medium-term pain as the acquisition is bedded in (Q1 … clout of its post-acquisition $38bn market cap and country … related to the Wellcare acquisition to ensure the deal was … [...]